A groundbreaking twice-yearly HIV prevention injection, lenacapavir, is rolling out in Eswatini and eight other high-risk nations. Hailed as a potential pandemic-ender, its limited global scale and funding cuts threaten its lifesaving impact.
New HIV Shot Offers Hope Amid Funding Crisis
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →